Characterizing the interaction modes of PAR4 receptor with agonist and antagonist by molecular simulation approach

被引:0
作者
Lu, Nan [1 ,2 ]
Meng, Fancui [2 ]
Yuan, Jing [2 ]
Liu, Lei [2 ]
Wang, Yanshi [2 ]
Li, Lingjun [2 ]
Zhao, Tong [2 ]
Xu, Weiren [2 ]
Tang, Lida [2 ]
Xu, Youjun [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China
[2] Tianjin Inst Pharmaceut Res, Tianjin Key Lab Mol Design & Drug Discovery, Tianjin 300193, Peoples R China
关键词
PAR4; molecular docking; molecular dynamics; agonist; antagonist; PLATELET ACTIVATION; PROTEIN-STRUCTURE; IONIC LOCK; GENERATION; MECHANISM; EFFICIENT; PEPTIDE; BINDING;
D O I
10.1142/S0219633619500081
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Protease-activated receptor 4 (PAR4) is a promising target for antiplatelet therapy. In this study, homology modeling and molecular docking methods were used to investigate the binding modes of PAR4 agonists and antagonists. The outcomes show that agonists have good docking scores, and they also form more hydrogen bonds with PAR4 than antagonists. To reveal the different conformational changes caused by agonist and antagonist, molecular dynamic simulations were carried out on three selected PAR4 systems. Simulation results show that PAR4 activation involves breaking interactions of 3-7 lock switch (Try157 and Tyr322) and ionic lock switch (Arg188 and Asp173), and formation of transmission switch among Tyr161, Asn300 and Phe296. In addition, principal component analysis (PCA) indicates that the major change for agonist bound system takes place in the intracellular region while that for antagonist bound system is in the extracellular region. The binding free energy of BMS-986120 is much lower than AYPGKF, suggesting high affinity of antagonist. Moreover, the electronegative aspartic residues Asp230 and Asp235 at ECL2 are important for PAR4 binding to agonist. Clarifying the PAR4 structural characteristics may be helpful to understand the activation mechanism, giving insights into the molecular design and discovery of novel potential PAR4 antagonists in the future.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Combined spectroscopies and molecular docking approach to characterizing the binding interaction of enalapril with bovine serum albumin
    Pan, Dong-qi
    Jiang, Min
    Liu, Ting-Ting
    Wang, Qi
    Shi, Jie-hua
    LUMINESCENCE, 2017, 32 (04) : 481 - 490
  • [42] Exploring molecular insights into the interaction mechanism of cholesterol derivatives with the Mce4A: A combined spectroscopic and molecular dynamic simulation studies
    Khan, Shagufta
    Khan, Faez Iqbal
    Mohammad, Taj
    Khan, Parvez
    Hasan, Gulam Mustafa
    Lobb, Kevin A.
    Islam, Asimul
    Ahmad, Faizan
    Hassan, Md Imtaiyaz
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 111 : 548 - 560
  • [43] Combined spectroscopies and molecular docking approach to characterizing the binding interaction between lisinopril and bovine serum albumin
    Jiang, Min
    Huang, Chuan-ren
    Wang, Qi
    Zhu, Ying-yao
    Wang, Jing
    Chen, Jun
    Shi, Jie-hua
    LUMINESCENCE, 2016, 31 (02) : 468 - 477
  • [44] Structural insights from an in silico molecular docking simulation of complement component 3a receptor 1 with an antagonist
    Misawa, Kensuke
    Sugai, Yoshiya
    Fujimori, Taketoshi
    Hirokawa, Takatsugu
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2021, 106 (106)
  • [45] Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins - m2 antagonist binding to the muscarinic m2 subtype receptor
    Kapp, OH
    Siemion, J
    Eckelman, WC
    Cohen, VI
    Reba, RC
    RECEPTORS & SIGNAL TRANSDUCTION, 1997, 7 (03): : 177 - 201
  • [46] Investigation of the molecular interaction between apraclonidine, an α2-adrenergic receptor agonist, and bovine serum albumin using fluorescence and molecular docking techniques
    Kucuk, Ipek
    Kucuksahin, Oyku Buket
    Yildirim, Merve
    Kabir, Md. Zahirul
    Silah, Hulya
    Celik, Ismail
    Uslu, Bengi
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2025, 326
  • [47] Molecular-Interaction and Signaling Profiles of AM3677, a Novel Covalent Agonist Selective for the Cannabinoid 1 Receptor
    Janero, David R.
    Yaddanapudi, Suma
    Zvonok, Nikolai
    Subramanian, Kumar V.
    Shukla, Vidyanand G.
    Stahl, Edward
    Zhou, Lei
    Hurst, Dow
    Wager-Miler, James
    Bohn, Laura M.
    Reggio, Patricia H.
    Mackie, Ken
    Makriyannis, Alexandros
    ACS CHEMICAL NEUROSCIENCE, 2015, 6 (08): : 1400 - 1410
  • [48] Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis
    Le, Hien Thi Thu
    Murugesan, Akshaya
    Ramesh, Thiyagarajan
    Yli-Harja, Olli
    Saravanan, Konda Mani
    Kandhavelu, Meenakshisundaram
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 189 : 142 - 150
  • [49] Molecular Insights into the Interaction of Tryptophan Metabolites with the Human Aryl Hydrocarbon Receptor in Silico: Tryptophan as Antagonist and no Direct Involvement of Kynurenine
    Badawy, Abdulla A-B
    Dawood, Shazia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (09):
  • [50] Molecular dynamics simulation of the human adenosine A3 receptor:: agonist induced conformational changes of Trp243
    Hallmen, Christian
    Wiese, Michael
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (10-11) : 673 - 684